Contributing to global tuberculosis control through innovative research and training:
From Bench to Bedside and Beyond.

Read More

Subscribe to the JHU-CTB mailing list!

Where we Work

Events

TB Clinical and Epidemiology Lunch Meeting

Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

Click for More Information

Updates

A randomized trial of HPV self-sampling as an...

OBJECTIVE: Women living with HIV experience higher risk of cervical cancer, but screening rates in the United States are lower...

Read More

Evaluation of a nurse practitioner-physician...

Background Treatment success rates for multidrug-resistant tuberculosis (MDR-TB) in South Africa remain close to 50%. Lack of...

Read More

The epidemiological advantage of preferential...

Tuberculosis (TB) remains disproportionately concentrated among the poor, yet known determinants of TB reactivation may fail to...

Read More

Daily rifapentine for treatment of pulmonary...

RATIONALE: Rifapentine has potent activity in mouse models of tuberculosis chemotherapy but its optimal dose and exposure in...

Read More

Development of a novel lead that targets M....

Widespread resistance to first-line TB drugs is a major problem that will likely only be resolved through the development of new...

Read More